月度归档： 2025 年 8 月

HIGHLIGHTS:- The Group’s gross billings amounted to approximately RMB1,705.4 million, representing an increase of approximately 83.3% from approximately RMB930.5 million for the Corresponding Period.- The Group’s total revenue was approximately RMB2,099.7 million, representing an increase of approximately 133.8% from approximately RMB898.1 million for the Corresponding Period.- The profit attributable to Shareholders of the Group was approximately RMB865.4 million, as compared to the net loss attributable to Shareholders of approximately RMB174.2 million for the Corresponding Period.- Taking into account the financial and cash flow positions of the Group, the Board recommends the payment of an interim dividend of approximately HKD238.9 million for the six months ended June 30, 2025, representing HKD0.51 per share (in cash).HONG KONG, Aug 29, 2025 - (ACN Newswire via SeaPRwire.com) - JF SmartInvest Holdings Ltd (the “Company” ; together with its subsidiaries, the "Group" or “we”) is pleased to announce its unaudited consolidated interim results for the six months ended June 30, 2025 (the “Reporting Period”). During the Reporting Period, the Company sustained robust operations and realized a revenue of approximately RMB2,099.7 million, representing a YOY growth of approximately 133.8%. Profit attributable to Shareholders amounted to approximately RMB865.4 million, representing a YOY turnaround to profit from the net loss attributable to Shareholders of approximately RMB174.2 million in the Corresponding Period, and an increase of approximately RMB1,039.6 million in the Reporting Period. These fully demonstrate the effective strategy execution and high market adaptability of the Company.The Company places great emphasis on Shareholders returns. Taking into account the financial and cash flow positions of the Group, the Board recommends the payment of an interim dividend of approximately HKD238.9 million for the six months ended June 30, 2025, representing HKD0.51 per share (in cash). Maintaining a prudent dividend policy not only reflects the strong profitability of our core business and our ample cash flows, but also highlights our strong sense of responsibility and commitment to Shareholders returns. Since the listing of the Company in 2023, the Company has made cash dividend payments for consecutive years with increasing dividend payout ratio. Notably, the dividend payout ratio reached 50.3% for 2024.Developing a dimensional product matrix for revenue diversificationLeveraging on the synergy and conversion of the products under our existing four main product lines, we further strengthened our core advantages in “intelligent algorithms + professional investment research + ecosystem services”, drove the transformation of our next-generation stock investing assistants from “feature-focused” to “experience-orientated”, and continued to improve our digital financial infrastructure, thereby facilitating the development of personalized and inclusive financial services.We consolidated the foundation of our large-amount software products and delivered our expertise in investment advisory services to ensure robust and strong performance of the core business. Empowered by AI technology, we fully delivered our expertise in investment advisory by newly launching 8 stock monitoring indicators and the “FinSphere SmartInvest” quantitative product that further strengthened our AI service capabilities. At the same time, we advanced the framework construction of our Stock Learning Machine through forming the three main matrices of “content, tool and trading” with focus on six core modules such as courses, live streaming and tools, to create a comprehensive learning platform. During the Reporting Period, It underwent 5 major version iterations and over 200 feature optimizations.In addition, we refined our small-amount series products to enhance our product strengths and operational capabilities and accelerate the platform development of our App. We built a Chief IP ecosystem integrating K-line chart analysis and expert insights,that enabled us to precisely distribute contents through a user tagging system. We upgraded our market information by enriching data such as capital flow trends, Hong Kong and US stocks, and launched new features of stock monitoring and portfolio watchlist. We optimized our information page with an infinite content feed, personalized recommendations, and improved visual hierarchy. Meanwhile, we also expanded multiple distribution channels including app stores, and refined our marketing strategies through data analysis. By sorting out the bottlenecks in registered users’ activation, we implemented tiered strategies to enhance utilization rates. Our homepage was dynamically optimized to enhance the attractiveness of its first screen. These measures accelerated the development of our App platform, broadened our user coverage and product exposure, increased the trustworthiness and stickiness of our App and created a closed loop of “content nurtures users and trust drives conversion”.Adhering to Artificial Intelligence + Investment Advisory strategy and refining our “1+N” investment research systemWith focus on the “buyer-side investment advisory” service, we vigorously developed “AI+” and further strengthened our “1+N” investment research system to fully penetrate our investment research into businesses and processes, so as to professionally support our customers in creating long-term value. We continued to make significant investment and effort in research and development. During the Reporting Period, we invested approximately RMB147 million in R&D activities. Meanwhile, as of the end of the Reporting Period, we had 139 software copyrights and patents on product features, big data, and AI, that represented an increase of 21 YOY.We actively explored the all-round empowerment of AI in the securities sector. We practiced “AI + Investment Advisory” providing a one-stop intelligent investment research platform which consolidates the core strengths of comprehensive stock analysis, multi-dimensional stock profiling, and diverse quantitative stock selection, and delivers professional investment research capabilities in an accessible, personalized, and empathetic manner that suits different types of investors. Meanwhile, considering compliance as our lifeline, we built an intelligent compliance and risk control platform covering the entire business process that creates a closed compliance loop of complete activity logging, data traceability, risk blocking, intelligent quality inspection and human-machine collaboration. During the Reporting Period, the cumulative number of behavioral monitoring tasks conducted by our “AI Monitoring Officer” increased by over approximately 77% as compared with 940 million in the Corresponding Period, and our “AI Inspection Officer” for content quality inspection assisted in nearly 2.2 million review tasks, reflecting that full coverage has been basically achieved.Based on our “1 research institute and N business lines” investment research system with our JF Financial Research Institute at the core, we continued to refine our underlying business competitiveness in securities investment advisory. Guided by the principle of “conducting higher-dimensional research and providing lower-dimensional services”, the institute is committed to developing a domestically leading and characteristically distinctive investment research service platform in China to provide long-term and steady, systematic, trustworthy and professional research services for investors. As of the end of the Reporting Period, the institute established a pyramid team structure consisting of 4 experts, 9 super-IPs and 128 professionals. It studied over 4,000 companies in over 20 industries.Refining traffic operation on MCNs with AI empowerment to build a high-quality traffic systemBy capitalizing on our refined traffic operations and realizing traffic reuse, we effectively expanded our business scale and improved our profit margins through optimization of operational efficiency. During the Reporting Period, using AIGC to optimize content production, we enhanced the production efficiency of premium contents. Moreover, using Douyin as our primary channel, we established a multi-platform layout with focus on Kuaishou, Xiaohongshu and Bilibili, to extend the boundaries of traffic operation scenarios. As of the end of the Reporting Period, the Company operated 994 MCN accounts on different internet platforms. These accounts attracted approximately 63.06 million followers, representing an increase of 17.47 million as compared with the Corresponding Period.At the same period, we actively practiced investor education for greater brand influence. We joined the Investor Education Alliance of China Fund and opened a Yinghua account to provide inclusive, systematic and differentiated investor education content for investors, contributing to the long-term development of stock investing theory. We exclusively sponsored Chinese Business Network’s live broadcast of the Berkshire Hathaway Annual Shareholders Meeting for the sixth consecutive year. Through “Buffett and Seven Lunches”, we helped investors build cognitive understanding of investing, and we specially organized a US study tour, bringing nearly a hundred investors to attend the meeting in person so that they could directly ask the stock god questions about value investing. This created a dialogue between the general investors and the iconic investor, aiming to provide them with more diverse and down-to-earth investment advice and forward-looking insights. We also attended “Financial Powerhouse”, a featured program of China Central Television, to provide deep explanation and analysis of the paradigm shift of the Company’s “AI + Investment Advisory” services empowered by fintech.Business outlookThe chairman of the Board and chief executive officer of JF SmartInvest Holdings Ltd, Mr. Chen Wenbin said: "Consistently adhering to the concepts of rational investing, value investing and long-term investing, we insisted on adopting a customer-centric approach to develop a dimensional product system and continuously improve our services. Looking forward to future, we, as a next-generation stock investing assistant, will continue to strengthen our competitiveness, solidify our market leadership and strive to make investing and wealth management easier yet more professional, and enhance the happiness of investment and wealth management. "About JF SmartInvest Holdings Ltd (Stock Code: 9636)JF SmartInvest Holdings Ltd is a new generation stock investment assistant. The Company is engaged in the provision of equity investment instruments, securities investment advisory, investor education and other services to individual investors. The products include stock quote software, stock learning machine, Stock Navigator, Super Investor and Jiuyao Stocks. The Company adopts the technology + investment research model, develops JF Robo-Advisor, FinSphere Agent, FinSphere Report and other products based on artificial intelligence (AI) and big data technology, which are applied to the industry in terms of innovative practice and scenario application.For enquiries, please contact:Financial PR (HK) LimitedEmail: ir@financialpr.hkTel: 852 2610 0846Fax: 852 2610 0842 Copyright 2025 ACN Newswire via SeaPRwire.com.

业绩摘要：- 截至2025年6月30日止六个月(「回顾期」)的收益约为18.3亿港元，较去年同期增加约7.8%。收益增加主要由于本集团持续的自然增长(主要在欧洲及澳洲地区)，并借着我们于2025年1月完成收购泰国最大的牙科实验室Hexa Ceram Company Limited(「Hexa Ceram」)而加快。- 截至2025年6月30日止六个月的毛利率约为54.8%；毛利约为10.1亿港元，较去年同期增加约10.0%。- 本集团于截至2025年6月30日止六个月的EBITDA约为4.6亿港元，较去年同期增加约21.6%。- 本集团截至2025年6月30日止六个月的纯利约为2.9亿港元，较去年同期增加约34.7%。- 截至2025年6月30日止六个月的每股基本盈利为30.37港仙。- 董事会已宣派截至2025年6月30日止六个月的中期股息每股普通股10.7港仙。- 截至2025年6月30日止六个月，本集团于中国内地、泰国及越南生产设施生产之数码化解决方案个案(海外及国内)增加至约457,653件，较2024年同期增加24.4%，原因为客户持续采用口腔内部扫描仪。香港, 2025年8月29日 - (亚太商讯 via SeaPRwire.com) - 8月28日，全球领先之义齿器材供应商-现代牙科集团有限公司（简称「现代牙科」或「本集团」，股份代号：03600.HK）欣然公布截至2025年6月30日止6个月之未经审核中期业绩。截至2025年6月30日止六个月，在牙科行业数码化趋势的持续支持下，本集团的多维度策略及持续提升的营运效率及生产力使其于本期间的收益、纯利及EBITDA均创下纪录。此情况在宏观经济环境充满挑战之时，包括牙科手术的需求普遍疲弱及贸易战的不确定性下仍能体现。本集团充分善用位于泰国、越南及中国内地的全球化生产设施，积极应对前所未有的国际贸易环境。全球数码化趋势持续推动整合义齿行业，让本集团进一步增加其于业内的市场份额。而我们数码化的持续转型有望改善顾客及患者的体验，可令本集团在竞争对手中脱颖而出，表现优于同行。凭借销售及经销网络的优势，我们于欧洲、北美、大中华、澳洲及其他国家的义齿行业均取得领先地位。欧洲市场业务自欧洲市场的销售收益占我们于回顾期间收益的最大部分。于回顾期间，欧洲市场录得收益约9.2亿港元，较截至2024年6月30日止六个月增加约9,734.1万港元。此地理市场占本集团收益总额约50.2%。欧洲市场收益增加是由于推出新产品(例如数码化义齿)及我们最先进的数码化流程，推动销售订单量增加。本集团已成为提供全面数码化解决方案的先驱，范围涵盖多项微创及美容义齿解决方案以至口腔内部扫描仪及透明矫正器，本集团已准备好把握牙科行业数码化趋势加速带来的机遇。本集团继续透过建立以教育及数码化为重点且贴近客户需求的牙科解决方案生态系统，积极从国际及本地竞争对手取得市场份额；并透过不同的境内及境外资源有效地满足我们客户的高期望。本集团一直致力并将继续装备好自己，为市场上的牙科领域提供最先进的数码化解决方案。北美市场业务自北美市场的销售收益占回顾期间收益的第二大部分。于回顾期间，北美市场录得收益约3.7亿港元，较截至2024年6月30日止六个月减少约1,964.5万港元。此地理市场占本集团收益总额约19.9%。虽然2025年上半年对主动美容治疗的需求仍然疲弱，我们的中央化数码流程及广泛的生产网络让我们为北美客户提供更高服务质素及营运效率。我们位于美国、中国、越南及泰国等地的多元化供应基地，在应对美国关税的不确定性时带来更大的弹性 - 使我们比其他竞争对手更具优势。虽然进口产品线的数码化起初带动整体市场个案的增长，然而2025年4月在美国实施的关税带来新的不确定性及为我们以进口为主的业务单位的后续销售带来下跌。大中华市场业务于回顾期间，大中华市场录得收益约2.9亿港元，较截至2024年6月30日止六个月减少约4,257.6万港元。此地理市场占本集团收益总额约16.0%。中国内地市场面对带量采购政策及持续价格竞争的逆境。此亦导致中国内地诊所积极于香港推广种植牙治疗(香港患者就诊人数明显减少)。本集团有意转移低利润业务，并专注于服务中及高价值客户，确保本集团业务能够长期及可持续获利。本集团对此市场的中长期前景感到乐观，特别是在政府最新的采购相关措施中，预计(i)规范义齿价格及建立价格透明度，促进公平竞争；(ii)让本集团领先的品牌名称及声望成为客户及顾客的主要考虑；及(iii)让本集团从其规模化的生产团队中得益及根据顾客或客户更有效分配资源。澳洲市场业务于回顾期间，澳洲市场录得收益约1.4亿港元，较截至2024年6月30日止六个月增加约995.6万港元。此地理市场占本集团收益总额约7.5%。澳洲的收益录得双位数增长，反映牙科行业数化码趋势带动更多新的数码化产品，以及收购Digital Sleep的收益贡献，但部分被相较于截至2024年6月30日止六个月，澳元兑港元贬值4.0%抵销所致。其他市场其他市场主要包括印度洋国家、马来西亚、台湾、新加坡及泰国。截至2025年6月30日止六个月，该等市场录得收益约1.2亿港元，较截至2024年6月30日止六个月增加约8,790.7万港元。此地理市场占本集团收益总额约6.4%。其他市场的收益增加主要由于新收购的Hexa Ceram的收益贡献所致。展望及策略全球宏观经济环境仍然不明朗，地缘政治挑战让全球各行业处于逆境当中。然而，本集团的业务遍及全球多个地区及市场，多元化的经营使其在面对该等挑战时享有独特优势。有别于在单一国家或有限地区经营的竞争对手，本集团均衡多元的国家风险策略，确保其在动荡时刻仍然坚毅不屈，平稳过渡。凭借全球布局及我们适应当地市场环境的能力，使本集团的表现优于竞争对手，并能把握新兴机遇。数码化势不可挡，带动义齿行业的整合。本集团于此趋势中尽享优势，凭借其中央化数码工作流程、先进的生产能力及全球化网络，旨在提升营运效率及提供卓越的客户体验。我们持续对数码化的投资不仅加强我们的竞争优势，亦加快行业的整合，本集团可以从中获得更大的市场份额。我们在过往多年作出多项标志性收购，包括最近于2025年1月收购泰国最大牙科实验室Hexa Ceram，本集团的全球分销及销售网络进一步多元化，加强在东南亚地区的影响力。是次扩张连同我们位于美国、中国、越南及泰国等地的多元化供应基地，让本集团在应对与贸易不明朗因素及其他地缘政治风险等相关的挑战时带来更高弹性。凭借董事会丰富的经验及克服短期挑战的决心，本集团已准备就绪，继续全力把握新商机，同时保持审慎及谨慎的态度，以保障股东利益。关于现代牙科集团现代牙科集团有限公司 (股份代号: 03600.HK) 为全球领先的义齿器材供应商、经销商和顾问，专注于发展迅速的义齿行业为客户提供定制式义齿。我们的产品组合大致可分为三类﹕固定义齿器材，例如牙冠及牙桥；活动义齿器材，例如活动义齿；及其他器材，例如正畸类器材、透明牙套、运动防护器及防鼾器。现代牙科集团拥有多个备受称许的全球品牌，包括西欧的Labocast、Permadental及Elysee Dental、中国的洋紫荆牙科器材、香港的现代牙科器材、美国的Modern Dental USA及MicroDental、澳洲及新西兰的Modern Dental Pacific、新加坡的Modern Dental SG、台湾的 Modern Dental TW、马来西亚的 Apex Digital Dental及泰国的Hexa Ceram等。我们提供稳定和优质的产品及卓越的客户服务，令这些公司品牌能茁壮成长。我们于全球超过 28个国家拥有超过 80 家服务中心及服务逾 30,000 名客户。 Copyright 2025 亚太商讯 via SeaPRwire.com.

2025年中期业绩表现要点：- 强劲增长：收入总额为港币20.68亿元，较去年同期大幅增长；- 扭亏为盈：报告期内，公司盈利港币6.50亿元，其中归属于本公司股东之盈利为港币3.99亿元，实现扭亏为盈；- 募资提升：旗下基金资产管理总规模（AUM）约港币1,194亿元，期内新增募资约港币27.41亿元；- 退出良好：基金及自有资金层面合计退出金额港币20.18亿元，退出回报倍数（MOIC）约2.78倍；- 控本增效：强化精益管理，经营成本同比下降10%，财务费用同比下降38%；- 流动性充裕：拥有现金及现金等价物约港币81亿元；- 稳健派息：中期股息为每股港币0.05元。香港，2025年8月29日 - (亚太商讯 via SeaPRwire.com) - 中国光大控股有限公司（「光大控股」，股份代号：165.HK）公布截至2025年6月30日止6个月（「报告期」）之中期业绩。2025年上半年，中国私募股权行业逐步迈入更加稳健的发展阶段。光大控股充分发挥耐心资本优势，保持战略定力，准确把握市场机遇，及时调整募投管退策略，夯实核心主业，价值潜能逐步释放，公司整体经营质效大幅改善，业绩强劲复苏。报告期内，光大控股实现收入总额为港币20.68亿元，较去年同期大幅增长港币21.82亿元，主要得益于投资收入的大幅增加，充分展现了公司良好的投资眼光和长期投资底蕴。公司盈利港币6.50亿元，其中归属于本公司股东之盈利为港币3.99亿元，较去年同期净亏损港币12.82亿元成功实现扭亏为盈，业绩显著改善。与此同时，公司继续强化精细管理，保持健康稳健的经营发展。期内，经营成本同比下降10%，主动压减杠杆，计息负债比率对比2024年末减少2%，控本增效成果显著，财务费用同比下降38%。公司流动性保持充裕，截至2025年6月底，拥有现金及现金等价物约港币81亿元。公司资源和业务重心继续向优势产品聚焦，进一步稳固核心主业。报告期内，新增募资约港币27.41亿元，旗下基金资产管理总规模（AUM）约港币1,194亿元，在管基金产品72只，涵盖一级市场基金、二级市场基金和母基金。期内，共计对9个项目进行投资，完全/部分退出项目46个。秉承与股东分享经营成果的发展理念，董事会宣派2025年中期股息为每股港币0.05元（2024年中期股息：每股港币0.05元）。2025年上半年经营要点一、发挥集团化运营优势，加强募资协同体系2025年上半年，公司新完成设立淮安洪泽光启基金和厦门海洋高新产业发展基金，总规模为人民币25亿元。淮安基金关注成长阶段的新能源、新材料和智能制造等项目，上半年已完成首期实缴到位；厦门海洋基金关注海洋科技成果孵化转化，助力海洋经济高质量发展。同时，多只基金已完成立项，目前正按照既定规划有序推进中。二、稳固核心主营业务，驱动业绩强劲复苏报告期内，公司基金及自有资金层面合计退出金额港币20.18亿元，完成小鹏汽车、大普通信、Taboola三笔完全退出，部分退出了软通动力、德康农牧、第四范式等多个项目，退出回报倍数（MOIC）约2.78倍，全面带动多只基金DPI提升，为基金LP带来了可观收益。Circle、德康农牧、网易云音乐等已上市项目在上半年均有良好的市场表现，为公司贡献较好的投资收益。二级市场基金上半年精准把握结构性机会，投资业绩表现较好，其中光大可转债机会基金荣获巴克莱评选的同类基金业绩排名的第二名。三、锚定科技创新战略，布局重点行业领域公司基于深刻的产业洞察和前瞻性的战略视野，在上半年加快投资节奏，重点聚焦人工智能、芯片半导体、生物医药等战略性新兴产业，基金层面合计投资约港币2.64亿元。培育并支持多家科技领军企业，包括长江存储和武汉新芯（国产存储芯片巨头）、恒翼生物（肿瘤及自免创新药研发企业）、钧嵌传感（国产工业自动化模块及新能源车核心传感器战略供应商）、钛动科技（大数据与BI领域服务商）等，支持中国科创企业做优做强。同时通过母基金支持金镒资本、钟鼎资本等优秀的子基金，发挥母基金资源放大、风险分散、收益多元的优势。四、优化经营管理，释放发展新动能公司持续优化融资结构，上半年把握国内降息周期，发行人民币30亿元的2025年第一期中期票据，年利率2.09%，创公司历史债券发行票面利率新低。报告期内，公司整体融资成本同比下降 133个基点至 3.14%，财务费用同比下降 38%，经营成本同比下降10%，降本增效成果显著。公司持续优化风险管理体系，通过推进风险资产分级分类、强化动态估值管理及构建风险监测预警机制，实现全流程风险防控效能提升。五、强化民生服务，商业消费更新升级光大控股发挥旗下产业优势，提升产品服务品质，以满足居民日益增长的消费服务需求。商业消费方面，旗下光大安石已在全国9个城市成功打造18座"大融城"购物中心，管理规模约260万平方米，创造了约3.77万个工作岗位，2025年上半年累计服务消费者约1.21亿人次，服务商户超过4500个。报告期内，北京重点消费类基础设施及城市更新项目「中关村ART PARK大融城」一期顺利开业，有效带动消费体验升级，扩大内需。六、重要投资企业稳中向好，韧性强劲中飞租赁主业发展稳健，经营质量和运营效率持续提升，股东应占净利润同比增长。截至2025年6月30日，中飞租赁机队规模达181架，租赁予22个国家及地区的41家航空公司。光大养老紧抓国内康养产业发展机遇，在全国49个城市拥有各类养老机构数量237个，提供养老床位3万余张，入住率提高1.77%。特斯联持续深化AI技术与多产业融合，驱动多行业智能化升级，落地国产化AI应用与数智方案，并荣获多项权威认证。七、强化构建ESG体系，推动可持续发展报告期内，公司持续推动ESG体系建设，公司MSCI（明晟）ESG评级维持为A级，并获得香港投资者关系协会（HKIRA）颁发的「BEST ESG（S）」奖项。公司切实发挥自身所能，履行企业公民责任担当，上半年共组织及参与各类文化和社会公益活动46次，服务人群超过万人，高标准履行社会责任。2025年上半年，在光大集团的坚强领导、董事会的带领和全体员工的共同努力下，公司经营质效全面改善，发展新动能持续增强，取得来之不易的成绩。随着中国经济的持续向好，政策支持力度的不断加强，中国私募股权行业将迈入高质量发展的新征程。光大控股将紧抓市场机遇，乘势而上，为实现"十五五"良好开局夯基固本。下半年，光大控股将继续坚持稳中求进的工作总基调，持续做好增收控本，优化经营管理，抢抓"募投管退"等关键业务环节的机遇，借助跨境平台和集团综合协同的势能，培育长期耐心资本，做好金融「五篇大文章」，通过科学的战略规划、专业的投资团队和严格的风险管理，持续为股东创造价值。 Copyright 2025 亚太商讯 via SeaPRwire.com.

HONG KONG, Aug 29, 2025 - (ACN Newswire via SeaPRwire.com) - Tianneng Power International Limited (the “Company”, together with its subsidiaries, collectively referred to as the “Group” or “Tianneng”), (Stock Code: 00819.HK) releases its interim report for the six-month period ended 30 June 2025.In the first half of 2025, adhering to the Group’s vision of Strategic Guidance and Reformation Breakthrough, Tianneng coordinated the three-wheeled strategy of Industry, Technology, and Capital. While solidifying the core competency of the lead-acid battery business, the Group also accelerated the expansion of overseas markets, released the Group’s built-up potential in new-energy battery, deepened the vertical construction of the battery recycle system, and drove the diversification of products and sustainability.Within the reporting period, the Group made a strategic pivot to reduce the trade business, achieved RMB 21.168 billion in revenue for the manufacturing business, which was stable compared to the same period in 2024, accounting for approximately 87.5% of the total revenue within the sector. In terms of the trade business, the Group realized an overall revenue of RMB 30.24 billion, which represented an 89.47% decrease from the same period of 2024. Within The manufacturing sector, the high-end eco-friendly battery business remained stable, providing a resilient financial support for the Group. The emerging businesses experienced significant growth, among which the Li-ion battery business achieved a revenue of RMB 0.501 billion, representing a 174.58% growth from the same period of 2024. Within the reporting period, the Group achieved a gross profit of RMB 2.537 billion, which is stable compared to the same period of 2024. In terms of operating cash flow, the Group achieved RMB 0.891 billion of net inflow, compared to a net outflow of RMB 0.162 billion in the same period of last year. Overall, in the first half of 2025, Tianneng demonstrated strong resilience, developmental momentum, and strategic commitment in a complex external environment.Internationalisation Accelerated, Overseas Expansion Bore FruitsInternational expansion is a vital fulcrum of the Group in strengthening global competitiveness and achieving incremental leaps. In the first half of 2025, the overseas business experienced remarkable growth with continuous positive feedback, achieving a revenue of RMB 0.226 billion, representing a 75.39% growth from the same period of 2024.Within the reporting period, guided by local demands, the Group accelerated its overseas expansion with global industrial resources, and set up operational teams in countries such as Thailand, Vietnam, and Turkey while developing a sales network in major areas including the Asia-Pacific, Europe, North America, the Middle-East and Africa. In addition, the Group’s production base in Vietnam is being constructed in an orderly manner while the capacity of the assembly base is robustly released, laying the groundwork for future developments in the region. The Group has developed customised products based on specific local demands and emphasised building localised operational teams, while advancing its “Overseas Service” strategy, and systematically constructed localised standards. With these developments, the Group was able to optimise its global supply chain and release future growth potentials.Core Business Stable and Resilient, with Promising Growth MomentumWithin the reporting period, the Group pursued a path of “Stability and Growth Duality” under a complex external environment and industrial structure re-balancing. The high-end eco-friendly battery business demonstrated resilience, achieving a revenue of RMB 18.292 billion, providing the vital financial stability for the Group. The high-end eco-friendly batteries are sealed, maintenance-less lead-acid batteries built with the Group’s innovation in design and manufacturing, highly adapting to the demands of the light electric vehicle market, with their cost and performance superiority, are also widely utilised in various fields, including backup power supplies, automobile batteries, and special-purpose industrial power batteries.The Group solidified its competencies in the core business, upgraded its intelligent manufacturing capabilities, improved the operational management system, consolidated its sales network, drove product quality and comprehensive market competitiveness growth, and fortified the resilience of lead-acid batteries in a complex market environment. Within the reporting period, the Group was able to effectively upgrade its manufacturing efficiency and supply-chain resilience through utilising intelligent manufacturing systems and equipment technology upgrades, while demonstrating effective results in cost management. Through the evolution of battery technologies and product upgrades, the Group constructed a differentiated product matrix targeting major fields of usage such as light electric vehicles, data centres, automobile start-stop batteries, and industrial power batteries,driving a service system upgrade with user value at its core, and organically merged the traditional sales network with an innovative digital ecosystem.Solidifying the Diversity of Technological Road-maps and Accelerating New Business Growth In the first half of 2025, the Group committed to the development of new-energy businesses, including Li-ion batteries, solid-state batteries, hydrogen fuel cells, and sodium-ion batteries, and systematically drove innovative breakthroughs, intelligent manufacturing upgrades, user-scenario extensions, and fostered new business growth. The Group’s Li-ion batteries business mainly targets power storage and low-speed power. Within the reporting period, the Group’s power storage and low-speed power business achieved major improvements both in terms of quality and quantity. Specific markets, such as industrial batteries and automobile A/C batteries, also saw improvements in market volume. Overall, the capacity utilisation of the Group’s new-energy business was significantly enhanced, with remarkable improvements in operational efficiency and revenue, RMB 0.501 billion, a 174.58% increase from the same period of 2024.The Group’s solid-state battery also achieved intermittent success within the three dimensions of high energy density, cycle longevity, and high-rate performance. The Group also formed strategic collaborations with industry leaders in the two-wheeled vehicle market and carried out solution testing with partners targeting the low-altitude flying vehicle market. The Group continued its investment in hydrogen fuel-cells with a full-chain R&D system and an expert team, with advanced products, began testing in user-scenarios such as two-wheeled vehicles, public transportation, heavy trucks, and special-purpose machinery, and collaborated with upstream and downstream partners in constructing an application ecosystem. The Group also spearheaded the development and application of sodium-ion battery technology, and conducted experiments for key metrics such as low-temperature and cycle longevity testing for scenarios such as power storage and automobile start-stop battery in a steady manner. Through the multi-roadmap approach, and the “technology breakthrough - user scenario verification - solution delivery” process, the Group’s new-energy business growth is gradually and steadily shifting from individual verification to chain-release, firmly supporting the business momentum.Strengthening the Recycling System and Fortifying Industrial CollaborationThe battery industry is at the core of the Group’s business, which systematically constructed a full-life industry chain of manufacturing, recycling, and reusing, forming a two-railed industry system of lead-acid battery and Li-ion battery, achieving efficient recycling. Within the reporting period, the recycling business of the Group achieved a revenue of RMB 1.8 billion, a 15.82% increase compared to the same period of 2024.As a leader in the recycling industry in China, the Group is continuously building an effective recycling network with front-end reach and back-end efficiency, promoting the efficiency of waste battery recycling empowered by the collaborative effort of businesses at scale, and achieving a top-of-industry recycling ratio of crucial materials. Within the reporting period, the Group continued to enhance the granularity and precision of the recycling process from recycling, processing, and reusing, improve the differentiating system for Li-ion battery recycling, and improve the resource synergies at core regions and user scenarios. Through uninterrupted exploration of technological potential and system performance optimisation, the Group was able to gradually achieve scale advantage and economic value of the recycling system, injecting continuous momentum for the industry.Looking forward, Tianneng will drive industrial upgrades through technological innovation, empower efficient operation through digitisation, rebuild the value-chain system through ecological collaboration, and seek growth through internationalisation. The Group will solidify its competencies in the lead-acid market, accelerate the research, application, and market expansion process of new energy batteries such as Li-ion battery and solid-state battery. The Group will strengthen its capabilities in battery recycling, enhance the collaborative efficiency of industry-chain integration while expediting its expansion into overseas markets and optimising localised operation, from product to service, and develop into a new-energy battery company that is competitive with a global vision. Finally, the Group will promote the convergence between its company values and social values with a growth mindset and build a new paradigm of sustainable and high-quality growth.About Tianneng Power International LimitedTianneng Power International Limited and its subsidiaries (collectively referred to as “Tianneng” or the “Company”), founded in 1986 and headquartered in China, has developed into a leading enterprise in the new energy battery and the light electric vehicle battery industry with a comprehensive manufacturing system and technological advantage. Tianneng was listed on the Main Board of The Stock Exchange of Hong Kong Limited (Stock Code: 00819. HK) in 2007. After nearly four decades of development, Tianneng has established lead-acid batteries as its core business, focusing on the market of motive batteries for light electric vehicles, while expanding its product in automotive start-stop systems, backup power for communication base stations and other diversified scenarios. The Company is also advancing the R&D, production and sales of lithium-ion batteries, hydrogen fuel cells, sodium-ion batteries and solid-state batteries, offering multi-technology battery solutions for special industrial vehicles, energy storage systems and other applications. Additionally, Tianneng strengthens its recycling economy initiatives around its core operations. Through a dual-track system for lead and lithium recycling, the Company achieves efficient resource regeneration and reuse, building a comprehensive ecosystem for the new energy industry. Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 29, 2025 - (ACN Newswire via SeaPRwire.com) - Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its interim results for the six months ended 30 June 2025 (the "Reporting Period"). The Group adopted “one horizontal, one vertical” as its core business strategy: horizontally, it extended a lean management system to advance multi-mode collaboration among medical institution alliances; vertically, it focused on specialty-specific innovation in medical diagnostics to fast-track the translation and implementation of new technologies and products. Meanwhile, the Group leveraged AI to enhance the comprehensive solutions for medical institution alliances, promoted the practical application of AI in healthcare scenarios, and continuously strengthened the value of empowering clinical practices, demonstrating strong operational resilience.In the first half of 2025, due to multiple factors, including the centralized drug-procurement program, cost controls of medical insurance, and fierce market competition, the Group’s short-term results did not meet expectations. However, the Group remained committed to product and business model innovation, and further refined the mechanisms and processes of its operational management. By adhering to lean operations, the overall performance has achieved significant improvements. During the Reporting Period, the Group’s gross profit margin reached approximately 34.0%, representing an improvement of approximately 4.4% over the overall gross profit margin for 2024. The net loss amounted to RMB55.4 million, a significant decrease of 56.1% compared to the same period last year. The joint construction business remained the Group’s largest business segment, which recorded the revenue of RMB180.3 million, accounting for 57.6% of the total revenue, increased by approximately 9.6% as compared with the same period last year, achieving significant outcomes in empowering medical alliance clients through in-depth services, paving the way for the Group’s long-term high-quality growth. During the Reporting Period, the Group’s diagnostic testing services recorded revenue of RMB313.2 millionSteadily implementing “one horizontal, one vertical” strategy, with notable achievements in hospital-enterprise partnerships“One horizontal” ——Extending lean management system to deepen diverse forms of collaboration within medical institution alliancesYunkang has been committed to developing an innovative service mode for the joint construction of medical institution alliances featuring “professionalism as the foundation, standardization as the core, digital intelligence as the means, synergization as the goal”. During the Reporting Period, the Group provided nearly 450 alliance clients with multi-scenario solutions tailored to different clinical needs, including AI+ digital intelligence solutions for medical institution alliances, comprehensive collaborations with medical laboratories, solutions for regional/pathology centers and precision medicine center, and specialty-based solutions for alliance development, among other multi-model collaboration services. By leveraging Yunkang’s strengths, the Group assisted healthcare institutions at all levels in enhancing service capabilities and expanding service coverage, established a hierarchical and coordinated healthcare service system, and promoted the development of regional hierarchical diagnosis and treatment services.During the Reporting Period, despite increasingly fierce market competition, the Group maintained solid growth in the joint construction business through continuous deep collaboration with leading hospitals and municipal and county-level hospitals, further consolidating its competitive advantage.“One vertical” ——Joint innovation platform for diagnostic testing serves as strong driver for R&DThe Group has always focused on “clinical needs”, continuously strengthening hospital-enterprise collaboration and pioneering the establishment of a joint innovation platform for diagnostic testing, driving business expansion and product competitiveness. During the Reporting Period, the Group forged joint diagnostic innovation partnerships with dozens of top-tier medical institutions nationwide, delivering a portfolio of testing products addressing multiple infectious syndromes, including respiratory tract infections, central nervous system infections, urinary tract infections, gynecological infections, and tuberculosis, as well as genetic testing products for personalized medication. Collectively, these innovative products have served nearly 300 clients across the country, and achieved sustained growth in testing revenue.During the Reporting Period, Yunkang and Guangdong Provincial People’s Hospital successively launched a series of new panel products covering respiratory tract infections, central nervous system infections, and invasive fungal infections, successfully creating a standardized incubation model for domestic hospital-enterprise research innovation and translation, as well as a “1+N” medical inspection collaboration network. Moreover, throughout the process of scientific and technological innovation, both parties have gained rich clinical experience. With the active involvement and sustained efforts of dozens of domestic diagnostic experts and scholars, they formulated the Expert Consensus on the Application of tNGS for Clinical Standardization, which was published during the Reporting Period in Chinese Journal of Laboratory Medicine, a leading journal in China’s diagnostic field. During the Reporting Period, Yunkang also maintained close collaboration with the First Affiliated Hospital of Guangzhou Medical University, one of China’s top-tier hospitals, and successfully developed a urinary tNGS product, advancing the clinical practice of precision diagnosis and treatment for urinary tract infections. Simultaneously, Yunkang partnered with the First Affiliated Hospital of Jinan University to establish a “university-hospital-enterprise joint innovation platform” and incubated and operated the “innovation project of psychiatric drug genetic testing”, which has successfully yielded genetic testing products for antidepressants, anti-anxiety drugs, and sedative-hypnotics.AI empowers multi-modal solutions for medical institution alliances, improving quality and efficiency to deepen client services  During the Reporting Period, Yunkang fully employed DeepSeek and achieved digital deployment across its platforms. Centered on the core concepts of “AI+” and “precision diagnostics”, Yunkang extensively applied artificial intelligence technology across the multi-technology platforms of its medical laboratories. Taking the in-depth integration of AI technology with Yunkang pathology diagnosis platform as an example, the per-slide efficiency of AI-empowered diagnostic was continuously optimized, achieving simultaneous improvements in intelligence, efficiency, and quality. Moreover, through the deployment of intelligent applications, Yunkang realized smart online customer services and the efficient review of results and reports, which fully streamlined diagnostic service processes and improved experience and satisfaction of its client services. In the process of jointly developing new technologies and products through hospital-enterprise R&D, Yunkang’s AI technology empowered product innovation and R&D across multiple aspects, including bioinformatics analysis, report interpretation, disease risk assessment, and development and translation of novel products, by leveraging the powerful data analysis, modeling, and predictive capabilities of large-scale AI models. This has accelerated the clinical implementation.Notably, Yunkang unveiled its medical AI model “ZhiYun” developed in collaboration with Runda Medical and Huawei, spanning the entire clinical workflow from pre-diagnosis to diagnosis and post-diagnosis. It will provide more efficient and convenient support and experience across all stages of clinical medical services. Meanwhile, Yunkang signed a strategic cooperation agreement with Runda Medical to strengthen in-depth collaboration across the industrial ecosystems in “AI + IVD + healthcare services”, jointly promoting the development and application of large-scale AI models in the medical field, and providing clients with digital-intelligence healthcare solutions. In the future, “ZhiYun”, the medical AI model, will be piloted in Yunkang’s healthcare partners and gradually rolled out nationwide, to improve quality and efficiency of medical institution alliance operations.Future prospects2025 marks the final lap for implementing the 14th Five-Year Plan. China has accelerated the capacity expansion of premium healthcare resources and their extension to lower-tier markets, resulting in a more balanced regional distribution. The country has also expedited the development of medical institution alliances and driven their upgrade from “framework building” to “high-quality operation”. Clinical treatment is also shifting from “broad-spectrum therapies” to “precision medicine”, with the growth potential of the industry continuing to be realized. At the same time, AI technology has continued to empower hierarchical diagnosis and treatment services, and the industry is embracing new growth opportunities.  Looking ahead, Yunkang will continue to keep pace with industry development trends and align with national policies, further strengthening the value of empowering clinical practices, and persistently exploring the “product innovation + business innovation” dual-pronged model to accelerate business development, deeply empower medical testing services, and benefit more residents.Yunkang Group Limited (Stock Code: 2325)Yunkang Group is a leading medical operation service provider in China, which started to provide standardized medical diagnostic services to medical institutions at all levels as early as 2008. Leveraging its own professional diagnostic capabilities and the nationwide service network of integrated healthcare systems, Yunkang has gradually grown to become a medical operation service platform. Meanwhile, Yunkang is a medical operation service provider in China offering a full suite of diagnostic testing services which are diagnostic outsourcing services and diagnostic testing services for medical institution alliances. Yunkang provides diagnostic services through on-site diagnostic centers to collaborative hospitals in the integrated healthcare systems in China and assists them in improving their clinical diagnosis capabilities through co-developing diagnostic centers. As of today, Yunkang has successfully provided professional services to nearly 450 on-site diagnostic centers. As of June 30, 2025, the hospitals we collaborated with were located across 31 provinces and municipalities in China. Copyright 2025 ACN Newswire via SeaPRwire.com.

Toronto, ON, August 28, 2025 - (ACN Newswire via SeaPRwire.com) - Digital Shovel, a leading innovator in crypto mining infrastructure solutions, is thrilled to announce the successful completion of its partnership with IREN (formerly Iris Energy Limited), marked by the delivery of the final batch totaling 493 MW of busway sets, including active units and spares. This milestone, achieved well ahead of schedule, underscores Digital Shovel’s commitment to excellence and reliability in supporting next-generation data center operations.The partnership, formalized in February 2024, saw Digital Shovel supply IREN with almost 500 MW of busways, critical to powering IREN’s expanding data centers, which are optimized for Bitcoin mining and AI cloud services using 100% renewable energy. The project was completed without delays, with deliveries consistently surpassing expectations, enabling IREN to advance its operational timeline.“We are incredibly proud of the seamless execution of this partnership with IREN,” said Scot Johnson, CEO of Digital Shovel. “Delivering all 493 MW of busway sets ahead of schedule is a testament to our team’s dedication and the strength of our innovative solutions. IREN’s vision for sustainable, high-performance data centers aligns perfectly with our mission, and we’re excited about the impact this project will have on their growth.”The early completion of this contract also positions both companies for future collaboration. “This project has been a fantastic opportunity to showcase what we can achieve together,” Johnson added. “We’re eager to explore new ventures with IREN as they continue to lead in renewable energy-powered data centers for Bitcoin mining and AI applications.”The success of this deployment lays the foundation for expanded collaboration as demand for infrastructure solutions continues to surge. With proven capacity to deliver at scale and speed, Digital Shovel is positioned to help power the next generation of energy-efficient data centers across North America.For more information about Digital Shovel and its solutions, please visit www.digitalshovel.com.About Digital ShovelDigital Shovel is a leading vertically integrated HPC, AI and Bitcoin Mining systems manufacturer, building critical elements for datacenter construction. This includes turnkey modular datacenters, as well as infrastructure including switchgear, Smart PDUs, busway systems and more. For more info, visit www.DigitalShovel.com About IRENIREN (NASDAQ: IREN), formerly Iris Energy Limited, is an Australia-based company operating next-generation data centers powered by 100% renewable energy. With facilities optimized for Bitcoin mining, AI cloud services, and other power-dense computing applications, IREN is a global leader in sustainable, high-performance data center solutions. For more information, visit www.iren.com.Media Contact:Press@DigitalShovel.comhttps://www.digitalshovel.com  Copyright 2025 ACN Newswire via SeaPRwire.com.

West Palm Beach, FL, Aug 28, 2025 - (ACN Newswire via SeaPRwire.com) - U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), has agreed to a multi-year partnership as the new title sponsor of The Palm Beaches Marathon. The U.S. Polo Assn. Palm Beaches Marathon, a race owned and managed by Ken Kennerly's K2 Sports Ventures, will be held in Downtown West Palm Beach, Florida, on December 13-14, 2025.USPA MarathonThis renowned marathon event is recognized for its beautiful views of the waterfront and palm-tree-lined streets and welcomes runners from across the country and around the world to the warmth of Florida during the cold winter months. It is also a qualifier for the legendary Boston Marathon."U.S. Polo Assn. is honored to be the Title Sponsor of The Palm Beaches Marathon, an iconic event that, like our brand, is deeply rooted in this vibrant community of Palm Beach County," said J. Michael Prince, President and CEO of USPA Global, the company that oversees the global, multi-billion-dollar U.S. Polo Assn. brand. "While our sport-inspired brand has a worldwide footprint in more than 190 countries, our heart and heritage are right here in The Palm Beaches, home to USPA Global, the United States Polo Association, and the USPA National Polo Center, the most prestigious polo destination in the world."The race weekend will include the 5K and 10K at 7:30 a.m. Saturday, December 13, followed by the featured Marathon, Half Marathon, and Marathon Relay on Sunday, December 14 at 6 a.m. Early registration is now open. Cost is $130 for the Marathon and $100 for the Half Marathon. The early registration fee for the 10K is $60, and $45 for the 5K. To register for The U.S. Polo Assn. Palm Beaches Marathon, visit palmbeachmarathon.com.A Health and Fitness Expo will coincide with race packet pickup on Friday, December 12, from 12 p.m. to 6 p.m. and Saturday, December 13, from 10 a.m. to 6 p.m. at the Meyer Amphitheatre, 104 Datura St., West Palm Beach. The Expo will feature the latest in health and fitness products and services, running apparel, and upcoming race information."We are excited to add a renowned global brand like U.S. Polo Assn. as the Title Sponsor of The Palm Beaches Marathon," Kennerly said. "This is a massive deal for the future of our race and its appeal to runners throughout the world. The Palm Beaches are a globally recognized blue-chip destination, and we are looking forward to continuing to grow the race not only in our community, but also on an international level."U.S. Polo Assn. brand products include apparel for men, women, and children, as well as accessories, luggage, watches, shoes, home furnishings, and more, with distribution across 190 countries through independent retail stores, department stores, U.S. Polo Assn. brand stores and e-commerce."Partnering with The Palm Beaches Marathon allows us to celebrate athletic excellence, community spirit, health and wellness, as well as the shared passion for sport that connects us locally and around the world. From the polo fields to the streets of Palm Beach, we are inspired by the athletes who give their all, and we look forward to sharing in the energy, camaraderie, and world-class competition that make The Palm Beaches Marathon truly special," Prince added.The race will support local charities, soon to be announced.WPBF 25, the Hearst-owned ABC Affiliate, will return as the Official Broadcast Station of the race and will provide extensive pre- and post-race coverage on all on-air and digital channels, as well as produce a live broadcast on Marathon race morning."WPBF 25 is thrilled to extend our partnership for a second year in a row as the Official Broadcast Station of the U.S. Polo Assn. Palm Beaches Marathon, reaffirming our commitment to help bring such a unique and exciting event like this to our community," said President and General Manager, Caroline Taplett. "Working together with our incredible partners, Ken Kennerly and the Marathon team, we are dedicated to promoting a more connected community, supporting local businesses, and inspiring participants, locally, nationally, and internationally to join us in beautiful South Florida for this one-of-a-kind experience."About U.S. Polo Assn.U.S. Polo Assn. is the official sports brand of the United States Polo Association (USPA), the largest association of polo clubs and polo players in the United States, founded in 1890 and based at the USPA National Polo Center (NPC) in Wellington, Florida. This year, U.S. Polo Assn. celebrates 135 years of sports inspiration alongside the USPA. With a multi-billion-dollar global footprint and worldwide distribution through more than 1,100 U.S. Polo Assn. retail stores as well as thousands of additional points of distribution, U.S. Polo Assn. offers apparel, accessories, and footwear for men, women, and children in more than 190 countries worldwide. The brand sponsors major polo events around the world, including the U.S. Open Polo Championship®, held annually at NPC in The Palm Beaches, the premier polo tournament in the United States. Historic deals with ESPN in the United States, TNT and Eurosport in Europe, and Star Sports in India now broadcast several of the premier polo championships in the world, sponsored by U.S. Polo Assn., making the thrilling sport accessible to millions of sports fans globally for the very first time.U.S. Polo Assn. has consistently been named one of the top global sports licensors in the world alongside the NFL, PGA Tour, and Formula 1, according to License Global. In addition, the sport-inspired brand is being recognized internationally with awards for global growth. Due to its tremendous success as a global brand, U.S. Polo Assn. has been featured in Forbes, Fortune, Modern Retail, and GQ as well as on Yahoo Finance and Bloomberg, among many other noteworthy media sources around the world. For more information, visit uspoloassnglobal.com and follow @uspoloassn.About The U.S. Polo Assn. Palm Beaches MarathonThe U.S. Polo Assn. Palm Beaches Marathon is a premier winter running event held annually in West Palm Beach, which features a range of race distances designed for runners of all abilities, including a full marathon, half marathon, 10K, 5K, and a 4-person marathon relay. Highlighted by a 100% flat, USATF-certified course, the Marathon serves as a Boston Marathon qualifier. The scenic route allows runners to experience West Palm Beach's vibrant downtown as it winds along palm-lined Flagler Drive, past historic neighborhoods, and features sparkling waterfront views. The event also supports community and charity efforts. Visit palmbeachmarathon.com.Contact InformationStacey KovalskyU.S. Polo Assn.skovalsky@uspagl.com(954) 673-1331Gary FermanSpecialty Sports(954) 558-5203SOURCE: U.S. Polo Assn. Copyright 2025 ACN Newswire via SeaPRwire.com.